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Abstract
Background: Salmonella enterica serovar Heidelberg ranks amongst the most prevalent causes of
human salmonellosis in Canada and an increase in resistance to extended spectrum cephalosporins
(ESC) has been observed by the Canadian Integrated Program for Antimicrobial Resistance
Surveillance. This study examined the genetic relationship between S. Heidelberg isolates from
livestock, abattoir, retail meat, and clinical human specimens to determine whether there was a link
between the emergence of MDR S. Heidelberg in chicken agri-food sources and the simultaneous
increase of MDR S. Heidelberg in human clinical samples.
Results: Chromosomal genetic homogeneity was observed by pulsed-field gel electrophoresis
(PFGE), DNA sequence-based typing (SBT) and DNA microarray-based comparative genomic
hybridization (CGH). Sixty one percent of isolates were indistinguishable by PFGE conducted using
XbaI and BlnI restriction enzymes. An additional 15% of isolates had PFGE patterns that were
closely related to the main cluster. SBT did not identify DNA polymorphisms and CGH revealed
only genetic differences between the reference S. Typhimurium strain and S. Heidelberg isolates.
Genetic variation observed by CGH between S. Heidelberg isolates could be attributed to
experimental variation. Alternatively, plasmid content was responsible for differences in
antimicrobial susceptibility, and restriction fragment length polymorphism (RFLP) analyses followed
by replicon typing identified two divergent plasmid types responsible for ESC resistance.
Conclusion: Due to the overall limited genetic diversity among the isolates, it was not possible to
identify variable traits that would be suitable for source tracking between human and agri-food
isolates of S. Heidelberg in Canada.
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Background
Non-typhoidal serovars of Salmonella enterica subspecies
enterica are responsible for outbreaks and sporadic occur-
rences of gastrointestinal illness that result in significant
human morbidity worldwide [1]. Human salmonellosis
in North America is attributed primarily to S. enterica sero-
vars Typhimurium and Enteritidis, with other serovars
that vary in regional prevalence constituting the remain-
der [2,3]. Due to the high incidence of S. Typhimurium
and S. Enteritidis, serotyping alone is not sufficient to
establish the chain of transmission from putative animal,
environmental or food sources to human cases. Serotyp-
ing in combination with other more discriminatory meth-
ods such as phage typing, pulsed-field gel electrophoresis
(PFGE), DNA sequence-based typing (SBT), comparative
genomic hybridizations (CGH) or plasmid profiling may
provide useful subtyping information. For example, sero-
typing has been used in combination with PFGE to suc-
cessfully link S. enterica isolates recovered from agri-food
products to outbreak-associated cases of human salmo-
nellosis [4,5].
S. Heidelberg is a member of Salmonella enterica subspe-
cies enterica serogroup B and is highly prevalent in both
Canada and the United States, but is infrequently reported
in European countries [3,6]. In Canada, S. Heidelberg
consistently ranks with S. Enteriditis and S. Typhimurium
as one of the top three most prevalent causes of human
salmonellosis, accounting for between 12–20% of human
clinical  Salmonella  isolates reported annually between
2000 and 2005 [2]. S. Heidelberg is also one of the most
common Salmonella serovars isolated from broiler chick-
ens and egg laying flocks in Canada and accordingly out-
breaks of human S. Heidelberg infections have been
associated with consumption of contaminated poultry
products including chicken, chicken nuggets and eggs
[7,8]. Other modes of transmission such as person-to-per-
son spread or direct contact with infected animals have
rarely been reported [7].
The Canadian Integrated Program for Antimicrobial
Resistance Surveillance was established by the Public
Health Agency of Canada (PHAC) in 2002. CIPARS col-
lects information regarding antimicrobial resistance
trends amongst enteric pathogens isolated from human
clinical specimens, livestock and retail meat sources to
assess the human health risk associated with the use of
antimicrobials in food animal production. CIPARS has
noted that S. Heidelberg was frequently isolated from
poultry sources, with this serovar accounting for 72% of
all  Salmonella  isolates recovered from retail chicken in
2004 [8]. In addition, there has been an increase in resist-
ance to multiple antibiotics, particularly extended spec-
trum cephalosporins (ESC), amongst S. Heidelberg
isolates from human and agri-food sources [2,8].
In this study, the genetic relationship between S. Heidel-
berg isolates from retail chicken, abattoir chicken ceca and
chicken, cattle, swine and human clinical samples was
examined using a variety of molecular methods. Our goal
was to identify variable genetic traits that would support
the investigation of potential linkages between human
multi-drug resistant (MDR) S. Heidelberg isolates and
MDR S. Heidelberg in chicken agri-food sources.
Results and Discussion
Genetic variation due to chromosomal determinants
Pulsed-field gel electrophoresis (PFGE) is frequently used
to subtype Salmonella [3,9] and has previously been used
to link cases of human salmonellosis with contaminated
agri-food products [4]. A comparison of PFGE data for all
107  S. Heidelberg isolates submitted by CIPARS to
PulseNet Canada from 2001 to 2004 for PFGE analyses
was retrospectively performed. PFGE identified limited
genetic diversity amongst these human and non-human
isolates originating from 5 provinces, as 61% of isolates
were indistinguishable by XbaI and BlnI PFGE (patterns
SHEXAI.0001 and SHEBNI.0001, respectively; data not
shown). An additional 15% of the isolates differed from
pattern SHEXAI.0001 by 1–3 fragments and therefore
meet the criteria of being closely related to this restriction
pattern [10]. The lack of genetic diversity observed using
PFGE therefore makes this method unsuitable for identi-
fication of epidemiological links between human and
agri-food isolates. Thus a subset of up to 39 strains (Table
1; Figure 1) representing a diverse range of temporally and
geographically distinct S. Heidelberg isolates with differ-
ent PFGE types, sources, sites of isolation, phage types and
resistance phenotypes were selected for examination by
additional subtyping methods.
DNA sequence-based typing (SBT) was conducted on S.
Heidelberg strains using a previously published scheme
examining the fimA, manB, and mdh loci. This SBT scheme
has previously been shown to distinguish amongst some
Salmonella isolates of the same serovar, including S. Agona
and S. Typhimurium [11]. Ten S. Heidelberg isolates were
selected from human, chicken, turkey and bovine sources
(including both ESC resistant and susceptible isolates, if
available) for examination by SBT (Table 1; Table 2). No
nucleotide polymorphisms were observed amongst 2502
bp sequenced from each of these strains therefore the
application of this method offered no additional discrim-
ination.
Comparative genomic hybridization (CGH) between S.
Heidelberg genomic preparations (Table 1) and a DNA
microarray based upon S. Typhimurium LT2 was used to
attempt to identify variable regions or traits between S.
Heidelberg strains that were not detected by either PFGE
or SBT. The CGH data indicated that there were severalBMC Microbiology 2008, 8:89 http://www.biomedcentral.com/1471-2180/8/89
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Table 1: Bacterial strains used in this study and PCR-based replicon typing and resistance gene characterization for S. Heidelberg and 
E. coli blacmy-2 plasmids.
Straina Year PTb Provincec Source Resistance 
Phenotyped
Resistance 
Genotypee
blacmy-2 plasmid 
mediated resistance 
determinantse
Reph
01–7169 2001 29 ON Human stool Amp, Chl, Cro, Gen, 
Kan, Str, Sxt, Tio
aadA2, strA, sul1 n/a n/a
02–0102 2001 11a ON Human stool Chl, Str, Sul aadA1, aadA2 n/a n/a
02–2339fg 2002 19 ON Human stool Sensitive n/a n/a n/a
02–4660fg 2002 19 ON Human stool Amc, Amp, Chl, Fox, 
Str, Sxt, Tet, Tio
blacmy-2, dhfrA1, floR, 
strA, sul1, tetA
blacmy-2, dhfRA1, floR, 
strA, sul1, tetA
A/C
02–5785f 2002 AT02–5785 ON Human stool Amc, Amp, Chl, Fox, 
Gen, Kan, Smx, Str, 
Tet, Tio
blacmy-2, floR, strA, 
sul1, tetA
n/i n/a
02–5980 2002 29 QC Human blood Amc, Amp, Fox, Tio blacmy-2 blacmy-2 I1
03–0262fg 2003 41 QC Human blood Amc, Amp, Fox, 
Cep, Cro, Tio
blacmy-2 blacmy-2 I1
03–0845f 2003 29 ON Human stool Amc, Amp, Fox, 
Cep, Chl, Gen, Kan, 
Smx, Str, Tet, Tio
aadB, blacmy-2, cmlA, 
strA, sul1, tetA
aadB, blacmy-2,cmlA, 
strA, sul1, tetA
A/C
03–3012 2003 4 QC Human blood Amc, Amp, Cep, 
Cro, Fox, Tio
blacmy-2 blacmy-2 I1
03–4601 2003 AT03–4601 QC Human blood Amc, Amp, Cep, 
Chl, Cro, Fox, Tio, 
Smx, Str, Tet, Tio
blacmy-2, floR, strA, 
tetA
blacmy-2, floR, strA, 
tetA
A/C; I1
03–4690 2003 32 ON Human stool Amc, Amp, Cep, 
Cro, Fox, Gen, Str, 
Tet, Tio
blacmy-2, strA, tetB blacmy-2 I1
03–7402fg 2003 29 ON Human blood Amc, Amp, Cep, 
Cro, Fox, Tio
blacmy-2 blacmy-2 I1
04–0346fg 2004 54 QC Human stool Amc, Amp, Cep, 
Chl, Cro, Fox, Smx, 
Str, Tet, Tio
blacmy-2, floR, strA, 
tetA
blacmy-2, floR, tetA A/C
04–1511 2004 41 ON Human stool Amc, Amp, Cep, 
Fox, Smx, Str, Tet, 
Tio
blacmy-2, strA, tetA blacmy-2 I1
04–3194 2004 29 ON Human blood Amc, Amp, Cro, 
Fox, Tio
blacmy-2 blacmy-2 I1
04–3293 2004 29a QC Human blood Amc, Amp, Cro, 
Fox, Tio
blacmy-2 blacmy-2 I1
04–4717 2004 29 QC Human blood Amc, Amp, Cro, 
Fox, Tio
blacmy-2 blacmy-2 I1
05–5435 2004 29 QC Human blood Amc, Amp, Cro, 
Fox, Tet, Tio
blacmy-2 blacmy-2 I1
04–5511fg 2004 41 ON Human stool Sensitive n/a n/a n/a
05–4260 2001 29 ON Bovine passive Amc, Amp, Cep, 
Fox, Tio
n/d n/a n/a
05–4262fg 2001 Untypable AB Chicken passive Amc, Amp, Cep, 
Chl, Fox, Gen, Kan, 
Smx, Str, Tet, Tio
blacmy-2, floR, strA, 
sul1, tetA
blacmy-2, floR, strA, 
sul1, tetA
A/C; I1
05–4263g 2001 Untypable ON Chicken passive Amc, Amp, Cep, 
Fox, Tet, Tio
blacmy-2, tetB blacmy-2 I1
05–4264 2002 Atypical ON Bovine passive Amc, Amp, Cep, 
Chl, Fox, Gen, Kan, 
Str, Sxt, Tet, Tio
aadA1, blacmy-2, 
dhfRA1, floR, strA, 
sul1, tetA
n/i n/a
05–4269fg 2003 29 ON Turkey passive Amc, Amp, Cep, 
Fox, Tio
blacmy-2 blacmy-2 I1
05–4272 2003 29 QC Chicken retail Amc, Amp, Cep, 
Fox, Tio
blacmy-2 blacmy-2 I1
05–4275 2003 32 QC Chicken retail Amc, Amp, Cep, 
Fox, Gen, Str, Tet, 
Tio
blacmy-2, strA, tetB blacmy-2 I1
05–4277 2003 29 QC Chicken retail Amc, Amp, Cep, 
Fox, Tio
blacmy-2 blacmy-2 I1BMC Microbiology 2008, 8:89 http://www.biomedcentral.com/1471-2180/8/89
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bacteriophage-related determinants that were putatively
divergent or absent amongst all of the S. Heidelberg iso-
lates in reference to S. Typhimurium LT2 (Figure 2). These
included the Fels-1, Fels-2 and Gifsy-1 prophage genes,
which is an observation similar to previous CGH studies
that demonstrated variable carriage of prophage genes
amongst Salmonella serovars [12-14]. Comparison of the
CGH patterns between S. Heidelberg isolates identified
limited strain-to-strain variation between isolates, with
the exception of STM0691–STM0709 (Figure 2). The fldA,
miaB, potE and furR loci encoded in this putatively diver-
gent region were amplified and sequenced from 5 S. Hei-
delberg isolates (05–1147, 00–5440, 03–7402, 05–4262
and 02–4660) however, no nucleotide polymorphisms
were observed throughout these gene sequences (data not
shown). These data indicated that the minimal strain-to-
strain differences identified by CGH may actually be due
to experimental variation rather than actual biological dif-
ferences. In addition, the limited genomic diversity
between S. Heidelberg isolates identified by this microar-
ray-based method may be representative of the true level
of diversity, however, the lack of S. Heidelberg specific
sequences on the array may have prevented the ability to
distinguish between isolates. In the absence of a
sequenced S. Heidelberg genome, CGH studies based on
a S. Heidelberg-specific microarray platform are not cur-
rently possible.
Resistance Determinants
Resistance phenotypes were determined by minimum
inhibitory concentration [10] testing (Table 1). The iso-
lates were then screened by PCR to determine the corre-
05–4287 2003 29 ON Chicken abattoir Amc, Amp, Cep, 
Fox, Tio
blacmy-2 blacmy-2 I1
05–4294 2004 29 ON Chicken retail Amc, Amp, Cep, 
Fox, Tio
blacmy-2 blacmy-2 I1
05–4299 2004 29 ON Chicken abattoir Amc, Amp, Cep, 
Fox, Tio
blacmy-2 blacmy-2 Unknown
05–4316f 2004 29 PE Bovine passive Amc, Amp, Cep, 
Fox, Tio
blacmy-2 blacmy-2 I1
05–4354fg 2004 41 QC Porcine passive Amc, Amp, Cep, 
Fox, Tio
blacmy-2 blacmy-2 Unknown
05–4355 2004 29 QC Porcine passive Amc, Amp, Cep, 
Fox, Tio
blacmy-2 blacmy-2 I1
00–5440 2000 29 AB Human Sensitive n/a n/a n/a
05–1147 2005 29 QC Human Sensitive n/a n/a n/a
539 unknown n/d ON Chicken rinse Sensitive n/a n/a n/a
564 unknown n/d ON Egg yolk mix Sensitive n/a n/a n/a
1170 unknown n/d ON Cocoa beans Sensitive n/a n/a n/a
S-467 1948 n/d BC Human Sensitive n/a n/a n/a
E. coli 830 2004 n/d AB Chicken abattoir Amc, Amp, Cep, 
Fox, Gen, Smx, Str, 
Tet, Tio
aadA1, blacmy-2, sul1 aadA1, blacmy2 Unknown
E. coli 831 2004 n/d QC Chicken abattoir Amc, Amp, Chl, Fox, 
Kan, Smx, Str, Tet, 
Tio
aadA1, blacmy-2, floR, 
strA, sul1, tetA
aadA1, blacmy-2, floR, 
strA, tetA
A/C
E. coli 832 2004 n/d QC Porcine abattoir Amc, Amp, Cep, 
Chl, Fox, Smx, Str, 
Tet, Tio
blacmy-2, floR, strA, 
tetA
blacmy-2, strA, tetA, 
floR
A/C
E. coli 833 2004 n/d ON Chicken abattoir Amc, Amp, Cep, 
Fox, Gen, Smx, Str, 
Tio
aadA1, blacmy-2, floR, 
sul1
aadA1, blacmy2 I1
E. coli 834 2004 n/d QC Bovine retail Amc, Amp, Cep, 
Fox, Tio
blacmy-2, blacmy-2 blacmy2 I1
a All strains are S. Heidelberg unless identified otherwise
b PT, phage type; n/d, not determined
c AB, Alberta; BC, British Columbia; PE, Prince Edward Island; QC, Quebec; ON, Ontario
d Amc, amoxicillin-clavulanic acid; Amp, ampicillin; Fox, cefoxitin; Tio, ceftiofur; Cro, cefriaxone; Cep, cephalothin; Chl, chloramphenicol; Gen, 
gentamycin; Kan, kanamycin; Nal, nalidixic acid; Str, streptomycin; Sul, sulfamethoxazole; Tet, tetracycline; Smx, sulfizoxazole; Sxt, trimethoprim-
sulfamethoxazole. n/a, not applicable.
e aadA1, streptomycin/spectinomycin adenyltransferase; aadB, aminoglycoside adenyltransferase; cmlA, chloramphenicol/florphenicol efflux; dhfR, 
dihydrofolate reductase; floR, efflux; strA, streptomycin phosphotransferase; sul1, dihydropteroate synthase; tetA, efflux; tetB, efflux; blacmy-2, beta-
lactamase. n/a, not applicable; n/i, plasmid not isolated; n/d, not determined.
f CGH were conducted on these isolates
g DNA sequence-based typing was performed on these isolates
h n/a, not applicable
Table 1: Bacterial strains used in this study and PCR-based replicon typing and resistance gene characterization for S. Heidelberg and 
E. coli blacmy-2 plasmids. (Continued)BMC Microbiology 2008, 8:89 http://www.biomedcentral.com/1471-2180/8/89
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sponding genotypes and to examine whether the
resistance genotypes of isolates could be indicative of the
isolate source (Table 1; Table 2). All S. Heidelberg isolates
that exhibited an ESC resistance phenotype were PCR pos-
itive for the blacmy-2 gene, with the exception of a single
bovine isolate (05–4260). The blacmy-2  gene was also
responsible for the ESC resistance phenotype of five E. coli
isolates included in the study to represent other sources of
ESC resistance determinants disseminating in the agri-
food continuum along with S. Heidelberg. The DNA
sequence of the blacmy-2 gene was identical amongst all of
the S. Heidelberg isolates and the five E. coli.
Tetracycline resistance was mediated by a combination of
tetA and tetB genes in S. Heidelberg and solely tetA in E.
coli (Table 1). Chloramphenicol resistance was mediated
by aadB, cmlA, floR and streptomycin resistance was medi-
ated by strA alone or in combination with either aadA1 or
aadA2 or both. Trimethoprim resistance was mediated by
the dhfRA1 gene. Sulfizoxazole/sulfamethoxazole resist-
ance was mediated by the sul1 gene in 6 of 9 S. Heidelberg
isolates. The gene mediating sulfizoxazole/sulfamethoxa-
zole resistance in the remaining 3 isolates was not identi-
fied. The carriage of the sul1 genes by isolates indicated the
possible presence of class I integrons [15]. Accordingly,
class I integrons could be amplified from 5 S. Heidelberg
and 3 E. coli isolates (Table 3). The S. Heidelberg integron
amplicons were either 1.2 or 3.0 kbp and DNA sequenc-
ing identified several resistance determinants carried
within the variable region of the integrons in addition to
sul1 carried within the 3' conserved segment (Table 3).
The integron amplified from strain 02–5785 could not be
Dendrogram of S. Heidelberg DNA macrorestriction patterns generated using XbaI Figure 1
Dendrogram of S. Heidelberg DNA macrorestriction patterns generated using XbaI. Strains were selected to 
present a diverse range of patterns. Dendrogram was created using Applied Maths Bionumerics version 4.0 using unweighted 
pair group method (UPGMA) with a dice coefficient of similarity, 1% band tolerance and 1.5% optimization. The scale bar indi-
cates percent similarity.BMC Microbiology 2008, 8:89 http://www.biomedcentral.com/1471-2180/8/89
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Table 2: Oligonucleotides used in this study
Primer Targeta Sequence 5'-3' Product Size (bp) Annealing Temp Reference
aadA1F aadA1 TATCAGAGGTAGTTGGCGTCAT 484 54°C [25]
aadA1R GTTCCATAGCGTTAAGGTTTCATT
aadA2F aadA2 TGTTGGTTACTGTGGCCGTA 712 61°C [25]
aadA2R GATCTCGCCTTTCACAAAGC
cmy-2-1 blacmy-2 ACACTGATTGCGTCTGACG 1143 60°C [26]
cmy-2–2 AATATCCTGGGCCTCATCG
cmy-2–3 AGTTCTGGCCAGTATTTCG n/a sequencing
cmy-2–4 TGCAACCATTAAAACTGGC n/a sequencing
cmy-2–5 TTCCTTTTAATTACGGAAC n/a sequencing
dhfRA1F dhfRA1 GTGAAACTATCACTAATGGTAGCT 470 50°C [27]
dhfRA1R ACCCTTTTGCCAGATTTGGTACCT
fimAF fimA TCAGGGAGAAACAGAAAACTAAT 760 55°C [11]
fimAR TCCCCGATAGCCTCTTCC
fldA-R fldA TTAGGCGTTGAGGATGTCG 530 55°C This study
fldA-F GCAATCACTGGCATCTTTTTC
floRF floR AACCCGCCCTCTGGATCAAGTCAA 548 60°C [25]
floRR CAAATCACCGGCCACGCTGTATC
furR-F furR AAAGAAGGCTGGCCTGAAAG 452 50°C This study
furR-R TTATTTAGTCGCGTCATCGTG
intAF 3' CS GGCATCCAAGCAGCAAG variable 52°C [25]
intAR 5' CS AAGCAGACTTGACCTGG
intAF2a integron AACCTTTTTGGCCTCCAG n/a sequencing This study
intAF2b CCTCCAGCGCTTGTGTAG n/a sequencing
intAF3 TCAGTGTTAGTCCCATCTCC n/a sequencing
intAF4 ACTTTAGTTGGCGGTACTCC n/a sequencing
intAR3 CCATAAAACGAGCCGTAAAC n/a sequencing
intAR4 CAAACCTAGAAACGCAAAGA n/a sequencing
manBF manB CATAACCCGATGGACTACAACG 893 55°C [11]
manBR ACCAGCAGCCACGGGATCAT
mdhF mdh GATGAAAGTCGCAGTCCTCG 849 50°C [11]
mdhR TATCCAGCATAGCGTCCAGC
miaB-R miaB TAGAATCCTACGCCCAGCTC 1424 55°C This study
miaB-F GGGCTGTCAGATGAACGAG
pefA pefA TCACTGTCTCCTGGGCTTCT 219 50°C This study
pefA CTTCAGTCTGGCCACCTTTC
potE-R potE AATTCAAAACGCGGTGAGAC 1319 55°C This study
potE-F TGTCGTGCAGCTCACAATTC
rep1IF repI CGAAAGCCGGACGGCAGAA 139 50°C [17]
rep1IR TCGTCGTTCCGCCAAGTTCGT
repA/CF repA GAGAACCAAAGACAAAGACCTGGA 465 50°C [17]
repA/CR ACGACAAACCTGAATTGCCTCCTT
spvC1 spv AACTCCTTGCACAACCAAATG 230 50°C This study
spvC1 ACCATATCCCTGAGCACACTG
strAF strA AGCAGAGCGCGCCTTCGCTC 684 61°C [25]
strAR CCAAAGCCCACTTCACCGAC
sul1F sul1 TCACCGAGGACTCCTTCTTC 631 60°C [25]
sul1R AATATCGGGATAGAGCGCAG
tetAF tetA GCTACATCCTGCTTGCCTTC 210 70°C [28]
tetAR CATAGATCGCCGTGAAGAGG
tetBF tetB TTGGTTAGGGGCAAGTTTTG 659 64°C [28]
tetBR TTGGTTAGGGGCAAGTTTTG
tetGF tetG CCGGTCTTATGGGTGCTCTA 693 56°C [25]
tetGR CCAGAAGAACGAAGCCAGTC
thdFF thdF TTGATTTTCCGGATGAGGAG 1553 55°C This study
thdFR AGGCATTGACAAAGGTCAGG
a 3' CS; 3' conserved segment of class I integrons, 5' CS; 5' conserved segment of class I integrons. Primers intAF2a, intAF2b, intAF3, intAF4, intAR3 
and intAR4 were designed to sequence the intAF/intAR amplicon.BMC Microbiology 2008, 8:89 http://www.biomedcentral.com/1471-2180/8/89
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successfully sequenced. Identical integrons encoding the
dhfRA1 trimethoprim resistance determinant were ampli-
fied from 02–4660 and 05–4264. Three E. coli isolates car-
ried identical class I integrons encoding aadA1. Notably,
no class I integrons were amplified from chicken agri-food
isolates indicating that these isolates have acquired resist-
ance determinants by other mechanisms.
Genetic Variation Attributable to the carriage of Plasmids
The genetic diversity between isolates examined by PFGE,
SBT and CGH was limited at chromosomal determinants
thus no genetic traits suitable for use in source tracking
could be identified. However, different resistance determi-
nants and integrons were observed therefore the plasmid
content of the isolates was determined to examine
another possible source of genetic variation. The total
plasmid content amongst sensitive isolates and isolates
resistant to one or more antimicrobial varied due to the
carriage of two high molecular weight (HMW) plasmids:
one common to all strains and a larger plasmid present
only in ESC resistant strains. The common plasmid may
represent the HMW virulence plasmid that has been
described in other S. enterica subsp enterica serovars [16],
however, the virulence determinants spv, pefA and rck were
not detected in the S. Heidelberg strains by PCR (data not
shown). One or more low molecular weight (LMW) plas-
mids ranging from 3 to 6 kbp were also observed in each
strain regardless of resistance phenotype (data not
shown).
Isolation of plasmids mediating cephalosporin resistance
was achieved by electroporating the total plasmid prepa-
ration from individual ESC resistant isolates into One
Shot® TOP10 Electrocomp™ E. coli cells. Transformant col-
onies containing ESC resistance determinants were
selected with cefoxitin and the blacmy-2 gene was amplified
by PCR from all of the transformant strains. Transformant
colonies could not be obtained using plasmid DNA prep-
arations from strains 02–5785 and 05–4264. Of the two
HMW plasmids originally observed in the S. Heidelberg
strains, only the larger plasmid was isolated from all
cefoxitin resistant transformants. Restriction fragment
length polymorphism (RFLP) analyses were performed on
the resistance plasmids using BglII to determine genetic
relatedness (Figure 3). The presence of the blacmy-2 gene on
this HMW plasmid (hereafter referred to as the blacmy-2
plasmid) was confirmed by Southern blot of the RFLP
fragments. The blacmy-2 gene could be localized to the larg-
est RFLP (~20 kbp) fragment in all isolates with the excep-
tion of two human blood isolates (03–3012 and 02–
5980; data not shown). The 1.2 kbp and 3.0 kbp integrons
encoded by isolates 02–4660 and 03–0845 respectively,
were localized to the blacmy-2 HMW plasmid by screening
the blacmy-2 transformant colonies by PCR and by South-
ern blot of the RFLP fragments (Table 3). The integron
amplified from isolates 05–4264, 01–7169 and 02–5785
could not be localized to the blacmy-2  HMW plasmid
because the plasmid could not successfully be isolated
from these strains or they did not harbour HMW plasmids
(Table 3).
The blacmy-2 plasmids extracted from E. coli transformants
exhibited diverse RFLP patterns (Figure 3) suggesting that
multiple plasmid backbones were involved in the emer-
gence of ESC in S. Heidelberg. Notably, isolates from dif-
ferent sources (i.e. human clinical and porcine clinical;
human clinical and chicken clinical or retail) had identi-
cal RFLP patterns. Identical RFLP patterns were also
obtained from S. Heidelberg 05–4294 and E. coli 833
indicating that blacmy-2 plasmids are successfully trans-
ferred between species. The horizontal transfer of blacmy-2
plasmids between bacterial species and the transfer of the
blacmy-2 gene between plasmid backbones limits the utility
of plasmid characterizations to discern the epidemiologic
DNA microarray-based comparative genomics of S Heidelberg Figure 2
DNA microarray-based comparative genomics of S. Heidelberg. Array probes represent the linear order of S. Typh-
imurium LT2 coding sequences from left to right, and with the Salmonella genomic island 1 (SGI1) present at the far-left side. 
White denotes similarity to LT2, green denotes putative divergence and red represents putative duplication or copy number 
change. The region STM0691–0704 which was putatively divergent between S. Heidelberg strains is represented by "A". Clus-
ters of bacteriophage-related determinants that are divergent in S. Heidelberg compared to S. Typhimurium: B, STM0892–0929 
(Fels-1 prophage); C, STM2584–2636 (Gifsy-1 prophage); D, STM2694–2739 (Fels-2 prophage).BMC Microbiology 2008, 8:89 http://www.biomedcentral.com/1471-2180/8/89
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relationships amongst isolates. RFLP analyses were also
performed on the full plasmid preparations from S. Hei-
delberg sensitive and resistant S. Heidelberg isolates to
characterize the HMW plasmid common to all S. Heidel-
berg isolates (Figure 3). Restriction fragments of the com-
mon plasmid in the sensitive strains corresponded to
fragments in the resistant strains indicating that these
plasmids are similar between isolates.
Replicon typing schemes have recently been hypothesized
to be a more accurate method of determining plasmid
relationships than RFLP [17]. We investigated the ability
of a PCR-based replicon typing scheme to supplement
plasmid RFLP data. Two different replicons, repA/C and
repI1, were identified for the blacmy-2 plasmids by screening
the blacmy-2 transformants (Table 1). These plasmids were
also screened by PCR and Southern blot for individual
resistance determinants. All 7 blacmy-2 plasmids isolated
from 5 S. Heidelberg and 2 E. coli that encoded a repA/C
replicon also encoded multi drug resistance (combina-
tions of aadA1, dhfRA1, floR, strA, sul1, and tetA) (Table 1,
Figure 3). The presence of repA/C blacmy-2 plasmids that
carry resistance cassettes have also been identified
amongst S. Typhimurium isolates [18]. The class I inte-
grons localized to the blacmy-2 plasmid demonstrated a
mechanism for the generation of MDR. The repA/C plas-
mids had diverse RFLP patterns compared to the repI1
plasmids further indicating the mosaic nature of these
plasmids. The repA/C were unable to be transferred by
conjugation to the recipient E. coli strain RG192 with the
exception of 03–7402 that was conjugative.
The majority of the blacmy-2 plasmids isolated from both S.
Heidelberg and E. coli were shown to carry repI1 replicons
and only the blacmy-2 resistance gene was detected by PCR
and Southern blot (Table 1, Figure 3). All repI1 plasmids
tested successfully transferred by conjugation to a recipi-
ent E. coli strain with the exception of 04–3293. The con-
jugative ability of repI1 plasmids can help explain their
widespread presence amongst the S. Heidelberg isolates. A
single chicken-passive isolate was shown to carry both the
repA/C and repI1 replicons along with the blacmy-2, strA,
and floR resistance determinants. Three plasmids encod-
ing only the blacmy-2  resistance determinant did not
encode either the repA/C or repI1 replicons. The repA/C
MDR plasmids were isolated from human-clinical and
both chicken and porcine samples, and similarly, the repI1
plasmids were isolated from diverse sources, therefore
replicon typing could not be used to establish a link
between human illness and a particular agri-food S. Hei-
delberg source.
Conclusion
There was limited genetic diversity at the chromosomal
level amongst the S. Heidelberg isolates. Plasmid content
exhibited strain-to-strain variation and was responsible
for differences in antimicrobial susceptibility between iso-
lates. No suitable genetic trait was identified to permit
source tracking of human S. Heidelberg infections. How-
ever, the paucity of S. Heidelberg in other agri-food
sources such as pigs or cows indicates that chicken agri-
food products are the most likely source of human salmo-
nellosis among the commodities surveyed by CIPARS [8].
S. Heidelberg is also frequent in clinical turkey samples
[8], but CIPARS does not currently routinely survey Salmo-
nella in turkey at the abattoir or retail level and the fre-
quency of S. Heidelberg in healthy turkey is unknown. It
is therefore possible that if the main reservoir for S. Hei-
delberg is poultry, amongst this population of strains
there is in fact limited overall genetic diversity and no
experimental method will identify epidemiologically sig-
nificant genetic traits.
In addition, this study demonstrates the elements respon-
sible for ESC resistance and MDR in S. Heidelberg. ESC
resistance of S. Heidelberg isolates could be attributed to
Table 3: Characterization of class I integrons encoded by S. Heidelberg and E. coli. Integrons were amplified using primers intAF and 
intAR [25] and sequenced using these same primers, and if necessary to achieve complete coverage, intAF2a, intAF2b, intAF3, intAF4, 
intAR3 and intAR4 (Table 2).
Isolate Source Integron length (kbp) Location Genes encodeda
01–7169 Human – stool 1.2 Unknown b aadA2
02–4660 Human – stool 1.2 HMW plasmid dhfRA1
02–5785 Human – stool 1.2 Unknown c nd
03–0845 Human – stool 3.0 HMW plasmid aadB, cmlA
05–4264 Bovine – passive 1.2 Unknown c dhfRA1
E. coli 830 Chicken – abattoir 1.0 HMW plasmid aadA1
E. coli 831 Chicken – abattoir 1.0 HMW plasmid aadA1
E. coli 833 Chicken – abattoir 1.0 HMW plasmid aadA1
a aadA1, streptomycin adenyltransferase; aadA2, streptomycin/spectinomycin adenyltransferase; aadB, aminoglycoside adenyltransferase; cmlA, 
chloramphenicol/florphenicol efflux; dhfrA1, dihydrofolate reductase; nd, not determined
b no HMW plasmids were observed in this strain
c HMW plasmids were observed, but could not be isolated from this strain after transformation attemptsBMC Microbiology 2008, 8:89 http://www.biomedcentral.com/1471-2180/8/89
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the carriage of blacmy-2 on HMW resistance plasmids and
other resistance determinants were localized to integrons.
Two resistance plasmids were observed: repA/C non-con-
jugative HMW plasmids encoding ESC resistance in com-
bination with other resistance determinants, and
conjugative repI1 plasmids encoded solely ESC resistance.
Methods
Bacterial strains
39 S. Heidelberg and 5 Escherichia coli isolates included in
this study were obtained from human clinical, retail, and
agri-food animal sources by CIPARS (Table 1). Antibiotic
susceptible S. Heidelberg isolates 1170, 539 and 564 were
provided by the Bureau of Microbial Hazards. Phage typ-
ing was performed as previously described [19].
Antimicrobial Susceptibility Testing
Resistance to antimicrobials was determined at the Labo-
ratory for Foodborne Zoonoses (LFZ) or the National
Microbiology Laboratory (NML) by broth microdilution
using the Sensititre™ ARIS Automated Microbiology Sys-
tem (Trek Diagnostic System Ltd, Cleveland Ohio). Break-
RFLP of the blacmy-2 plasmid using BglII Figure 3
RFLP of the blacmy-2 plasmid using BglII. Dendrogram created with Bionumerics version 4.0 using UPGMA with 
a fuzzy band coefficient of correlation, 2% optimization and 10% tolerance.A – indicates RFLP performed on the full 
plasmid profile isolated from resistant S. Heidelberg strains. B – indicates RFLP performed on the full plasmid profile from sen-
sitive S. Heidelberg strains. No scale bar is reported due to the high band tolerance settings used in this analysis.BMC Microbiology 2008, 8:89 http://www.biomedcentral.com/1471-2180/8/89
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points for resistance were taken from the NCCLS/CLSI
guidelines and were as follows: amoxicillin-clavulanic
acid; ≥ 32/16 μg/ml, ampicillin; ≥ 32 μg/ml, cefoxitin; ≥
32 μg/ml, ceftriaxone; ≥ 64 μg/ml, cephalothin; ≥ 32 μg/
ml, chloramphenicol; ≥ 32 μg/ml, ciprofloxacin; ≥ 4 μg/
ml, gentamicin; ≥ 16 μg/ml, kanamycin; ≥ 64 μg/ml, nali-
dixic acid; ≥ 32 μg/ml, sulfizoxazole/sulfamethoxazole; ≥
512 μg/ml, tetracycline; ≥ 16 μg/ml, trimethoprim-sul-
famethoxazole; ≥ 4/76 μg/mL [20] and ceftiofur; ≥ 8 μg/
ml [21]. The breakpoint used for streptomycin resistance
was ≥ 64 μg/ml [22]
Pulsed-field Gel Electrophoresis (PFGE)
PFGE was performed by PulseNet Canada at the NML
according to the PulseNet USA protocol using XbaI and
BlnI [23]. Pattern analysis and dendrogram construction
were performed using the BioNumerics version 4.0 soft-
ware package (Applied Maths, Austin, TX) with 1% toler-
ance and 1.5% optimization.
Genomic DNA extractions
Wild type S. Heidelberg or E. coli strains were used to inoc-
ulate 4 ml of Luria Bertani [17] broth (Invitrogen,
Carlsbad, CA). Alternatively, One Shot® TOP10 Electro-
comp™ (Invitrogen) E. coli transformants containing S.
Heidelberg blacmy-2 plasmids were inoculated into 6 ml LB
broth containing 20 μg/μl cefoxitin (Sigma-Aldrich,
Oakville, ON). Cultures were incubated overnight at
37°C with rotation at 200 rpm. Bacterial cells were col-
lected by centrifugation for 5 min at 5000 rpm and resus-
pended in 2 ml TE buffer (Sigma-Aldrich) (10 mM Tris-
HCL, 1 mM EDTA, pH 8.0). Lysozyme (Roche Diagnos-
tics, Indianapolis, IN) (0.5 mg/ml), RNase (Roche Diag-
nostics) (1.5 μg/ml), and proteinase K (10 mM Tris-HCL
pH 7.5, 20 mM CaCl2, 50% glycerol) (Sigma-Aldrich)
(0.12 mg/ml) were added to the cell resuspension mix-
ture. Following incubation at 37°C for 1 h, sodium
dodecyl sulphate (SDS) (Ambion, Austin, TX) was added
to a concentration of 0.1% (wt/vol) and the mixture was
incubated at 65°C until clearing occurred. The mixture
was then transferred to Phase Lock Light tubes (Eppen-
dorf, Hamburg Germany) for phenol-chloroform DNA
extraction using a volume of phenol-chloroform:isoamyl
alcohol (25:24:1) (Invitrogen) equal to that of the cell
resuspension mixture. Phenol-chloroform:isoamyl alco-
hol extraction was repeated until the aqueous layer was
clear. Following a final extraction with an equal volume of
chloroform (Fisher, Ottawa, ON), the aqueous layer was
transferred to a new tube. DNA was precipitated at -20°C
for 20 min using 0.6 vol of isopropanol (Fisher) and 0.1
vol 3 M sodium acetate (pH 5.5) (Ambion). Following
precipitation, DNA was washed with 70% ethanol and
resuspended in 200 μl TE buffer. DNA was quantified on
a NanoDrop ND-1000 (NanoDrop Technologies, Rock-
land, DE) and diluted to 20 ng/μl for use as PCR template.
PCR and DNA Sequencing
PCR reactions for tetA, tetB and tetG were performed using
1 unit of Fast start Taq DNA polymerase (Roche Diagnos-
tics) in a reaction mixture containing 1 × Fast start Taq
DNA polymerase buffer with MgCl2 (Roche Diagnostics),
1 mM MgCl2 (Roche Diagnostics), 0.2 μM dNTP mixture
(Invitrogen), 0.2 μM each primer (Table 2), 20 ng tem-
plate DNA and distilled water DNAse, RNAase free (Invit-
rogen) to 25 μl. The thermocycling parameters used for
tetA, tetB and tetG reactions containing Fast start Taq DNA
polymerase were: initial denaturation at 94°C for 5 min
followed by 35 cycles of denaturation at 94°C for 30 sec,
annealing at a primer specific temperature listed in Table
2 for 30 sec, extension at 72°C for 1 min followed by one
final extension at 72°C for 7 min. All other PCR reactions
were performed using 1 unit of Platinum Hifi Taq DNA
Polymerase High Fidelity (Invitrogen) in a reaction mix-
ture containing 1 × High Fidelity PCR Buffer (600 mM
Tris-SO4 [pH 8.9], 180 mM ammonium sulfate) (Invitro-
gen), 0.2 mM dNTP mixture (Invitrogen), 2 mM MgSO4
(Invitrogen), 0.3 μM each primer (Table 2), 20 ng tem-
plate DNA and distilled water DNAase, RNAase free (Inv-
itrogen) to 25 μl total volume. The thermocycling
parameters used for intA, potE and miaB PCR reactions
containing Platinum Hifi Taq were: initial denaturation at
94°C for 5 min followed by thirty cycles of denaturation
at 94°C for 30 sec, annealing for 30 sec, at a primer spe-
cific temperature listed in Table 2, extension for 60 sec
(intA) or 90 sec (potE, miaB) at 68°C followed by one final
extension at 68°C for 7 min. The thermocycling parame-
ters used for all other reactions containing Platinum Hifi
Taq were: initial denaturation at 94°C for 5 min followed
by 30 cycles of denaturation at 94°C for 30 sec, annealing
for 30 sec, at a primer specific temperature listed in Table
2, extension for 30 sec at 68°C followed by one final
extension at 68°C for 7 min. PCR amplicons were
resolved by agarose gel electrophoresis on 1.5% agarose
gels in 0.5× TBE buffer (Sigma-Aldrich) at 120 V for 60
min. Sequencing was conducted by the DNA Core facility
at the NML using an ABI3730 apparatus (Applied Biosys-
tems, Foster City, CA) with the primers used to generate
the template (Table 2). Complete sequencing of the blacmy-
2 PCR product required the design of additional sequenc-
ing primers listed in Table 2.
Comparative Genomic Hybridization
DNA microarrays were constructed as previously
described using 4492 commercially supplied 70-mer oli-
gonucleotides (Qiagen, Mississauga, ON) representing
the coding sequences of the S. Typhimurium LT2 genome
as well as all putative open reading frames from Salmonella
Genomic Island I (SGI1) [24]. Genomic DNA from test S.
Heidelberg and reference S. Typhimuirum LT2 strains was
isolated by phenol-chloroform extraction, sheared by
nebulization and labelled by Cy3 dCTP or Cy5 dCTPBMC Microbiology 2008, 8:89 http://www.biomedcentral.com/1471-2180/8/89
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incorporation as previously described [19]. Labelled DNA
from test and reference strains was hybridized to the array
as previously described with each test-versus-reference
comparison performed in triplicate and at least one of the
slides hybridized as a dye swap. Following hybridization,
slides were sequentially washed in buffer 1 (1 × SSC [3.0
M sodium chloride, 0.3 M sodium citrate] and 0.2 % SDS)
for 6 min at 56°C, buffer 2 (0.1 × SSC and 0.2 % SDS) for
4 min at room temperature, and twice in buffer 3 (0.1 ×
SSC) for 2 min at room temperature. Slides were scanned
using an Agilent DNA microarray scanner (Agilent Tech-
nologies, Mississauga, ON). Data analysis was conducted
as previously described to identify specific loci that were
absent or divergent between different S. Heidelberg
strains [19].
DNA sequence-based typing (SBT)
SBT was conducted using a previously published scheme
based on the fimA, manB, and mdh loci [11]. PCR and
sequencing were conducted using primers and annealing
temperatures listed in Table 2. Sequence analysis was car-
ried out using Seqman II (DNAstar Inc) and sequences
were concatenated to create allelic profiles for each strain.
Plasmid Profiles
A single colony was used to inoculate 8 ml of LB broth and
incubated overnight at 37°C with rotation at 200 rpm.
Complete plasmid profiles were isolated from 2 ml of
overnight culture using a QIAGEN plasmid mini kit (Qia-
gen) according to manufacturer's directions. Plasmids
were resuspended in 25 μl TE buffer (10 μM Tris-HCL pH
8.0, 1 μM EDTA) (Sigma-Aldrich) and resolved by gel elec-
trophoresis on 0.9 % agarose gels in 0.5 × TBE buffer
(Sigma-Aldrich) at 90 V for 90 min. Following staining for
20 min in ethidium bromide (2 μg/ml) and destaining for
20 min in ddH2O gels were visualized by UV transillumi-
nation using a BioRad GelDoc XR (Bio-rad). Plasmid size
was estimated using either a supercoiled DNA ladder (Inv-
itrogen) containing supercoiled plasmids ranging from 2
to 16 kbp.
Electroporation
Transformation of the plasmids encoding blacmy-2 was
achieved by adding 5 μl of the plasmid preparations to 50
μl OneShot® TOP10 Electrocomp™ E. coli cells (Invitro-
gen) in a 0.1 cm chilled cuvette (Cell Projects, Kent, UK).
A BioRad Gene Pulser (Bio-Rad) was used to apply a 1.25
kV pulse and 1 ml of S.O.C medium (Invitrogen) was
immediately added to the cuvette and the contents trans-
ferred to a sterile culture tube. Following incubation of the
transformation culture at 37°C for 60 min, 20 and 200 μl
aliquots were plated onto LB agar (Invitrogen) plates con-
taining 20 μg/ml cefoxitin (Sigma-Aldrich) and incubated
overnight at 37°C. Potential transformant colonies were
inoculated into 8 ml LB broth containing 20 μg/ml cefox-
itin and incubated overnight at 37°C with agitation. DNA
extractions were then conducted and PCR using the blacmy-
2 primer set was performed to verify transformants carried
the blacmy-2 gene.
Plasmid isolation from transformants
A single transformant colony was inoculated into 8 ml of
LB broth with 20 μg/ml cefoxitin and incubated overnight
at 37°C with rotation at 200 rpm to create a starter cul-
ture. Starter culture was diluted 1/500 into 150 ml LB
broth with 20 μg/ml cefoxitin and grown overnight at
37°C with rotation at 200 rpm. Plasmids were isolated
from 50 ml of overnight culture using a Qiagen plasmid
midi kit according to the manufacturer's directions with
the following modification: plasmid DNA was precipi-
tated using 2 ml 7.5 M ammonium acetate (Sigma-
Aldrich) in combination with 0.7 vol of isopropanol
(Fisher) and resuspended in 100 μl TE buffer.
Restriction Fragment Length Polymorphism (RFLP)
Purified plasmid DNA (25 μl) was digested overnight at
37°C with 20 units of BglII (New England Biolabs, Picker-
ing, ON). The resulting plasmid fragments were separated
by gel electrophoresis on 0.7 % Tris-acetate-EDTA (TAE)
(Gibco) agarose gels at 60 V for 6 h in TAE (400 mM Tris-
acetate, 10 mM EDTA). A 1 Kb Plus DNA Ladder (Invitro-
gen) and Track it λ DNA/Hind III fragments (Invitrogen)
were used as molecular size standards. Gels were stained
with ethidium bromide (2 μg/ml), destained overnight in
ddH2O at 4°C, visualised with UV transillumination and
photographed using a Bio-Rad Gel Doc XR. RFLP pattern
analysis and was conducted using Bionumerics version
4.0 software with 2% optimization and 10% tolerance. A
dendrogram based on RFLP patterns was generated in
Bionumerics using the unweighted pair group method of
analysis (UPGMA) with a fuzzy band logic coefficient of
correlation, 2% optimization, and 10% tolerance.
Southern Blot
RFLP gels were depurinated in 250 mM HCI for 12 min,
denatured in a 1.5 M NaCl, 0.5 M NaOH solution for 30
min and finally neutralized in a 1.5 M NaCl, 0.5 M Tris-
HCl pH 7.5 solution for 30 min. DNA was transferred by
capillary blotting to a positively charged nylon Hybond-
N+ (Amersham Biosciences, Little Chalfont, UK) mem-
brane using the TurboBlotter system (Schleicher &
Schuell, Keene, NH) according to manufacturer's direc-
tions with 10 × SSC (Ambion) transfer buffer. Membranes
were rinsed in 6 × SSC (Ambion) and DNA was fixed to
the membrane by UV treatment. Nucleic acid labelling
and detection was carried out following the manufac-
turer's directions using the ECL Direct Nucleic Acid Label-
ling and Detection System (Amersham Life Sciences, Little
Chalfont, UK). Labelled probes targeting the aadA1, blacmy-
2, dhfRA1, floR, strA, sul1, tetA, and tetB genes were gener-BMC Microbiology 2008, 8:89 http://www.biomedcentral.com/1471-2180/8/89
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ated from PCR products. PCR amplicons were purified
using the QIAquick PCR Purification Kit according to
manufacturer's directions, quantified on a NanoDrop
ND-1000 and diluted to 10 ng/μl. Amplicons (150 ng)
were denatured by boiling for 5 min and snap cooling on
ice for 5 min. Probe DNA was labelled at 37°C for 10 min
through the addition of equal volumes of DNA labelling
reagent (Amersham Life Sciences) and gluteraldehyde
(Amersham Life Sciences). Membranes were pre-hybrid-
ized at 42°C for 30 min in 25 ml pre-heated ECL gold
hybridization buffer (Amersham Life Sciences) containing
0.5 M NaCl and 5 % (w/v) blocking agent (Amersham Life
Sciences). Labelled probe was added to hybridization
buffer and hybridization was allowed to proceed over-
night at 42°C in a Fisher Isotemp hybridization oven
(Fisher). Following hybridization, excess probe was
removed by washing twice with primary wash buffer (0.5
× SSC, 0.4 % SDS) at 42°C for 20 min and twice with 2 ×
SSC for 5 min at room temperature. The presence of target
gene was detected on Hyperfilm ECL (Amersham) autora-
diography film according to manufacturer's directions.
Film was developed in a Feline™ developer (Fisher).
Conjugation
Salmonella Heidelberg strains were used as blacmy-2 plas-
mid donor strains. Recipient E. coli RG192 was serially
passaged against rifampicin (Sigma-Aldrich) until resist-
ance to 384 μg/ml was achieved. Cefoxitin (20 μg/ml) and
rifampicin (384 μg/ml) were used as selective agents for
the donor and recipient strains, respectively. Single colo-
nies of donor and recipient strains from selective plates
were inoculated into 8 ml of LB broth containing the
appropriate selective antibiotic and grown overnight at
37°C at 200 rpm. Overnight cultures were then sub-cul-
tured into LB broth without selective antibiotic and incu-
bated at 37°C for 5 h at 200 rpm. Recipient and donor
cells were combined in a 4:1 ratio in LB broth. Following
overnight incubation at 37°C, transconjugants were
selected by plating onto LB agar containing cefoxitin (20
μg/ml) and rifampicin (384 μg/ml). The transfer of blacmy-
2 was confirmed by performing PCR to detect the presence
of the blacmy-2 gene followed by isolation of plasmids from
E. coli transconjugants.
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